Apa/Enza-short Study: Shorter Treatment With Androgen Receptor Pathway Inhibitor in Patients With Low-volume Metastatic Castration-sensitive Prostate Cancer
PHASE3
The goal of this clinical trial is to evaluate the outcomes of a shorter tr...
A Study to Investigate the Safety and Tolerability of Oral INR731 Single Agent or in Combination With Androgen Receptor Pathway Inhibitor (ARPI) in Patients With Metastatic Prostate Cancer
PHASE1
The purpose of this study is to assess the safety, tolerability, pharmacoki...
An Observational Study to Learn More About Treatment Patterns and Factors Determining the Choice of Treatment in Canadian Men With Metastatic Hormone Sensitive Prostate Cancer in Routine Medical Care
N/A
This is an observational study in which only data are collected from adult ...
Status
Active Not Recruiting
Location
Pentavere
Start Date
2025-02-28
Trial ID
NCT06874114
RISK-ADAPT Protocol in Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
PHASE2
This is a prospective, interventional, non-randomized, phase 2 study to ass...
Status
Not Yet Recruiting
Location
Georgetown University Medical Center- Lombardi Comprehensive Cancer Center